Extensive research activities targeted towards exploring the potential functions of microRNA (miRNA) to design novel therapeutic solutions against different diseases is set to contribute to the adoption of miRNA instruments and consumables. These studies assist in understanding the mechanism of action of the signaling pathway, further integral to develop miRNA drug candidates. MicroRNAs role is in regulating gene expression, as their rapid adoption in the development of prognostic and diagnostic tools for various cancer types. Additionally, miRNAs are amongst the most important potential biopharmaceutical candidates that are entering in commercial space for developing potential future medicines.
MARKET SCOPE
The "Global Micro RNA (miRNA) Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Micro RNA (miRNA) market with detailed market segmentation by product, service, application, end user and geography. The report provides key statistics on the market status of the leading Micro RNA (miRNA) market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on Product, the global Micro RNA (miRNA) market is segmented into Instruments, Consumables.
- Based on Service, the market is categorised into Sample Collection, miRNA cDNA Synthesis, miRNA Profiling and Purification, Next Generation Sequencing (NGS), Microarray, Real Time PCR (RT-PCR), Others.
- Based on Application, the market is categorised into Cardiovascular Diseases, Cancer, Neurological Diseases, Immunological Disorders, Infectious Diseases, Others.
- Based on End User, the market is categorised into Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others.
MARKET DYNAMICS
Drivers:
- Advancement in the analytical methods that enable quantification and accurate detection of miRNA.
- Recent innovations in applications of MiRNAs.
- Rising initiatives for development of new therapeutics and diagnostics tests.
- Success of miRNA in clinical trials and technological advancements to support nucleic acid studies.
Restraints:
- High cost associated with the MicroRNA kits and other products.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Micro RNA (miRNA) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Micro RNA (miRNA) market in these regions.
IMPACT OF COVID-19 ON MICRO RNA (MIRNA) MARKET
The overall impact of COVID-19 pandemic is projected to remain positive for the Micro RNA (miRNA) market. As, researchers are exploring the role of micro-RNA in the management of SARS-COV-2 infection. Studies have indicated that miRNAs play a vital role in regulating innate and adaptive immune systems. Many studies have shown that the expression of miRNAs has a role in the host's response against the coronavirus and other respiratory viruses. Several in-silico experimentations have displayed that miRNA interactions with SARS-CoV-1 cause upregulation of some miRNA such as miR-574-5p, miR-17, and miR-214; helping in the inhibition of viral replication. Hence, studying the changes in miRNA expressions using sequencing instruments can contribute to understanding the pathogenesis of such chronic respiratory infections.
MARKET PLAYERS
The report covers key developments in the Micro RNA (miRNA) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Micro RNA (miRNA) market are anticipated to lucrative growth opportunities in the future with the rising demand for Micro RNA (miRNA) in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Micro RNA (miRNA) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Horizon Discovery Ltd.
- Synlogic
- QIAGEN
- GeneCopoeia, Inc.
- New England Biolabs
- Quantabio
- NanoString
- BioGenex